You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thorough QT

Showing 1 - 25 of 806
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

QT/QTc Trial in Austin (Ecopipam Hydrochloride, Moxifloxacin, Placebo)

Recruiting
  • QT/QTc
  • Ecopipam Hydrochloride
  • +2 more
  • Austin, Texas
    PPD Austin Phase 1 Clinical Research Unit
Apr 21, 2023

Healthy Trial in Overland Park (Rodatristat Ethyl, Moxifloxacin, Placebo for Rodatristat)

Recruiting
  • Healthy
  • Rodatristat Ethyl
  • +3 more
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc.
Jul 5, 2023

HSV Infection Trial in London (Pritelivir and moxifloxacin , Pritelivir , moxifloxacin and moxifloxacin , Pritelivir ,

Recruiting
  • HSV Infection
  • Pritelivir and moxifloxacin placebo
  • +2 more
  • London, United Kingdom
    Richmond Pharmacology Ltd
Jan 3, 2023

Pain Trial (VX-548, Moxifloxacin, Moxifloxacin Placebo)

Not yet recruiting
  • Pain
  • (no location specified)
Apr 5, 2023

Cystic Fibrosis Trial in Tempe (Vanzacaftor, Vanzacaftor Placebo, Moxifloxacin)

Recruiting
  • Cystic Fibrosis
  • Tempe, Arizona
    Celerion - Tempe
May 16, 2023

Healthy Subject Trial in Beijing (Orelabrutinib and (orelabrutinib tablet simulator), Orelabrutinib, Placebo (orelabrutinib

Active, not recruiting
  • Healthy Subject
  • Orelabrutinib and placebo (orelabrutinib tablet simulator)
  • +3 more
  • Beijing, China
    Beijing GoBroad Boren Hospital
Dec 19, 2022

Healthy Trial in Merksem (Aticaprant Supratherapeutic Dose, Aticaprant Therapeutic Dose, Placebo)

Completed
  • Healthy
  • Aticaprant Supratherapeutic Dose
  • +3 more
  • Merksem, Belgium
    Clinical Pharmacology Unit
Nov 9, 2022

Healthy Trial (BI 1015550, Moxifloxacin, Placebo)

Not yet recruiting
  • Healthy
  • BI 1015550
  • +2 more
  • (no location specified)
Nov 2, 2023

Cardiac Repolarization in Healthy Subjects Trial in Tempe (TD-4208 175 mcg, TD-4208 700 mcg, Placebo for TD-4208)

Completed
  • Cardiac Repolarization in Healthy Subjects
  • TD-4208 175 mcg
  • +3 more
  • Tempe, Arizona
    Celerion
Feb 22, 2022

Normal Healthy Subjects Trial (Eravacyline, Moxifloxacin, and )

Completed
  • Normal Healthy Subjects
  • Eravacyline, Moxifloxacin, and placebo
  • (no location specified)
Dec 16, 2021

Smoking Cessation Trial in Porto (Cytisinicline, Placebo, Moxifloxacin)

Completed
  • Smoking Cessation
  • Porto, Portugal
    BlueClinical Phase I
Jan 3, 2023

Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)

Recruiting
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Baltimore, Maryland
    PAREXEL Baltimore Early Phase Clinical Unit
Apr 13, 2023

Healthy Volunteers Trial in Antwerpen (P03277 0.1 mmol/kg, Moxifloxacin 400mg, NaCl 0.9%)

Completed
Has Results
  • Healthy Volunteers
  • P03277 0.1 mmol/kg
  • +3 more
  • Antwerpen, Belgium
    Clinical Pharmacology unit, SGS-Life Science Service
Mar 22, 2022

QTc Interval Trial in Overland Park (Psilocybin, Moxifloxacin, Micro-Crystalline Cellulose)

Recruiting
  • QTc Interval
  • Overland Park, Kansas
    Altasciences Clinical Kansas, Inc
Jul 26, 2022

Contraception Trial (Moxifloxacin, NOMAC-E2 (Org 10486-0 + Org 2317), Moxifloxacin )

Completed
  • Contraception
  • (no location specified)
Feb 7, 2022

Hyperuricemia, Gout, Qt Interval, Variation in Trial in Austin (LC350189 200mg, Placebo, Moxifloxacin 400mg)

Completed
  • Hyperuricemia
  • +2 more
  • LC350189 200mg
  • +3 more
  • Austin, Texas
    PPD
Dec 15, 2021

Abnormalities, Cardiovascular Trial in Dallas (Volanesorsen, Moxifloxacin, Placebo)

Completed
  • Abnormalities, Cardiovascular
  • Dallas, Texas
    Covance
Jan 13, 2022

Symptomatic Neurogenic Orthostatic Hypertension, nOH Trial in Tempe (Ampreloxetine <Dose A>, Ampreloxetine <Dose B>,

Completed
  • Symptomatic Neurogenic Orthostatic Hypertension
  • nOH
  • Ampreloxetine <Dose A>
  • +4 more
  • Tempe, Arizona
    Theravance Biopharma Investigational Site
Apr 19, 2021

Healthy Trial in Springfield (Relacorilant, Placebo to relacorilant, Moxifloxacin)

Completed
  • Healthy
  • Springfield, Missouri
    Single Site
Sep 10, 2021

Postoperative Pain Trial in London (SKY0402, Moxifloxacin 400mg, Placebo injection)

Completed
  • Postoperative Pain
  • London, United Kingdom
    Richmond Pharmacology Ltd
Feb 11, 2021

Healthy Trial in Austin (ALXN1840, Placebo, Moxifloxacin)

Unknown status
  • Healthy
  • Austin, Texas
    Clinical Research Site
Feb 11, 2021

Healthy Trial in Brussels (Sertraline, Moxifloxacin, Drug - Placebo)

Completed
  • Healthy
  • Brussels, Belgium
    Pfizer Clinical Research Unit
Jan 25, 2021

Electrocardiogram Repolarisation Abnormality, Gonococcal Infection Trial in Overland Park (AZD0914, Moxifloxacin, Placebo)

Completed
Has Results
  • Electrocardiogram Repolarisation Abnormality
  • Gonococcal Infection
  • Overland Park, Kansas
    Vince and Associates Clinical Research
Mar 26, 2020

Thorough QT/QTc Study Trial in Evansville (Inhaled loxapine, Inhaled , Oral moxifloxacin)

Completed
Has Results
  • Thorough QT/QTc Study
  • Inhaled loxapine
  • +3 more
  • Evansville, Indiana
    Covance Clinical Research Unit Inc.
Oct 29, 2019

Healthy Trial in Biberach (BI 409306, Moxifloxacin, Placebo matching to BI 409306)

Completed
  • Healthy
  • BI 409306
  • +2 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Sep 16, 2019